Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?
复制标题
晚期头颈癌放化疗后计划进行颈清扫术:对所有人都有必要吗?
DOI:
--
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
W. Wei
中科院分区:
文献类型:
--
作者:
P. Pellitteri;A. Ferlito;A. Rinaldo;J. Shah;R. Weber;J. Lowry;J. Medina;C. Gourin;K. Robbins;C. Suárez;A. Shaha;E. Genden;C. R. Leemans;J. Lefebvre;Luiz P. Kowalski;W. Wei
In the absence of large‐scale randomized trials evaluating dissection versus observation of the involved neck after neoadjuvant chemoradiotherapy, there is a need to collect data that will either support or ultimately refute a role for planned posttreatment neck dissection. A significant percentage of patients with extensive (N2 or N3) neck disease who demonstrate a complete response to chemoradiation therapy may harbor residual occult metastases, and identification of this subset of patients remains a clinical challenge. Because surgical salvage rates are greatly diminished when occult nodal disease becomes clinically manifest, planned posttreatment neck dissection is advocated but may not be necessary in all patients. The role of positron emission tomography chemoradiotherapy (PET‐CT) in this scenario remains unproven but holds promise in being able to identify which patients may be harboring residual disease in the neck after chemoradiotherapy. The implementation of as yet unidentified molecular tumor markers in combination with PET‐CT may ultimately prove to be effective in identifying patients who will best benefit from posttherapy neck dissection. Correlation of imaging results and pathologic node status will be important in determining the accuracy and, therefore, the value of this imaging modality for predicting the presence or absence of residual disease. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005
DOI:
10.1016/0360-3016(93)90489-i
发表时间:
1993
期刊:
International journal of radiation oncology, biology, physics
影响因子:
--
作者:
Armstrong,J;Pfister,D;Strong,E;Heimann,R;Kraus,D;Polishook,A;Zelefsky,M;Bosl,G;Shah,J;Spiro,R
通讯作者:
Spiro,R
影响因子:
45.3
作者:
Adelstein, DJ;Li, Y;Forastiere, AA
通讯作者:
Forastiere, AA
DOI:
10.1200/jco.1999.17.8.2390
发表时间:
1999
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Garden,AS;Glisson,BS;Ang,KK;Morrison,WH;Lippman,SM;Byers,RM;Geara,F;Clayman,GL;Shin,DM;Callender,DL;Khuri,FR;Goepfert,H;Hong,WK;Peters,LJ
通讯作者:
Peters,LJ